365 related articles for article (PubMed ID: 24741114)
1. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.
Liu Y; Chen J; Sethi A; Li QK; Chen L; Collins B; Gillet LC; Wollscheid B; Zhang H; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1753-68. PubMed ID: 24741114
[TBL] [Abstract][Full Text] [Related]
2. Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.
Li QK; Chen J; Hu Y; Höti N; Lih TM; Thomas SN; Chen L; Roy S; Meeker A; Shah P; Chen L; Bova GS; Zhang B; Zhang H
Sci Rep; 2021 Sep; 11(1):18936. PubMed ID: 34556748
[TBL] [Abstract][Full Text] [Related]
3. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.
Bedolla RG; Shah DP; Huang SB; Reddick RL; Ghosh R; Kumar AP
Mol Carcinog; 2019 Jun; 58(6):854-861. PubMed ID: 30859654
[TBL] [Abstract][Full Text] [Related]
5. Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential.
Ruela-de-Sousa RR; Hoekstra E; Hoogland AM; Souza Queiroz KC; Peppelenbosch MP; Stubbs AP; Pelizzaro-Rocha K; van Leenders GJLH; Jenster G; Aoyama H; Ferreira CV; Fuhler GM
Eur Urol; 2016 Apr; 69(4):710-719. PubMed ID: 26159288
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
[TBL] [Abstract][Full Text] [Related]
7. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.
Hayashi T; Oue N; Sakamoto N; Anami K; Oo HZ; Sentani K; Ohara S; Teishima J; Matsubara A; Yasui W
Pathobiology; 2011; 78(5):277-84. PubMed ID: 21849809
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
[TBL] [Abstract][Full Text] [Related]
9. Random forest-based modelling to detect biomarkers for prostate cancer progression.
Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
[TBL] [Abstract][Full Text] [Related]
10. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.
Cazares LH; Troyer D; Mendrinos S; Lance RA; Nyalwidhe JO; Beydoun HA; Clements MA; Drake RR; Semmes OJ
Clin Cancer Res; 2009 Sep; 15(17):5541-51. PubMed ID: 19690195
[TBL] [Abstract][Full Text] [Related]
11. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer.
Tian Y; Bova GS; Zhang H
Anal Chem; 2011 Sep; 83(18):7013-9. PubMed ID: 21780747
[TBL] [Abstract][Full Text] [Related]
12. RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z
Oncol Rep; 2017 Jun; 37(6):3209-3218. PubMed ID: 28440432
[TBL] [Abstract][Full Text] [Related]
13. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
15. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Kamoun A; Cancel-Tassin G; Fromont G; Elarouci N; Armenoult L; Ayadi M; Irani J; Leroy X; Villers A; Fournier G; Doucet L; Boyault S; Brureau L; Multigner L; Diedhiou A; Roupret M; Compérat E; Blanchet P; de Reyniès A; Cussenot O
Ann Oncol; 2018 Aug; 29(8):1814-1821. PubMed ID: 29945238
[TBL] [Abstract][Full Text] [Related]
17. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
18. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis.
Gao Y; Ha YS; Kwon TG; Cho YC; Lee S; Lee JN
Cancer Genomics Proteomics; 2020; 17(5):543-553. PubMed ID: 32859632
[TBL] [Abstract][Full Text] [Related]
20. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
